Benjamin G. Neel
Director of Research, Princess Margaret Cancer Centre (PMCC)
Dr. Benjamin G. Neel is the Director of Research of the Princess Margaret Cancer Centre.
Previously, Neel was a Professor of Medicine at Harvard Medical School and Director of the Cancer Biology Program at the Beth Israel Deaconess Medical Center (BIDMC) in Boston. He also served as the Deputy Director for Basic Research, Hematology Division at BIDMC from 2003-2007. He was appointed to the William B. Castle Chair of Medicine at Harvard Medical School in 2006.
Neel is an internationally recognized expert in the field of cellular signal transduction, with particular expertise in the biology and regulation of protein- tyrosine phosphatases. He was the inaugural recipient of the Gertrude Elion Award of the American Association for Cancer Research. He has also received a Junior Faculty Research Award from the Leukemia and Lymphoma Society and a National Institutes for Health (NIH) MERIT award. He has served on study sections and ad hoc review panels for the NIH, American Cancer Society (Massachusetts Division), the California Tobacco and Breast Cancer Research Programs, the Canadian Cancer Society and the Starr foundation. He also was a long time member of the Scientific Advisory Board of Ceptyr, Inc, is a current member of the Scientific Advisory Board of Kolltan Pharmaceuticals, and is a consultant for Novartis, Inc.
Neel earned a PhD in Viral Oncology from Rockefeller University in 1982 and an MD from Cornell University Medical School the following year. He then completed internship and residency in Medicine at Beth Israel Hospital, and is board-certified in Internal Medicine.